Biotechnology Industry Organization (BIO) Release: New Report Finds Biotechnology Companies are Participating in 39% of All Projects in Development for New Medicines and Technologies for Neglected Diseases

WASHINGTON--(BUSINESS WIRE)--Small- to medium-sized biotechnology companies are bringing innovation to global health, according to a report published today by BIO Ventures for Global Health (BVGH) and the Biotechnology Industry Organization (BIO). The report shows that 134 biotechnology companies are participating in neglected disease research and development, which represents participation in 39% of the 191 new drugs, vaccines, and diagnostics in development for neglected diseases such as malaria, tuberculosis, dengue fever, and others.

Back to news